Avacta Group Plc (OTCMKTS:AVCTF) Short Interest Update

Avacta Group Plc (OTCMKTS:AVCTF) was the recipient of a large growth in short interest in the month of January. As of January 30th, there was short interest totaling 105,622 shares, a growth of 92.3% from the January 15th total of 54,935 shares. Based on an average daily volume of 975 shares, the short-interest ratio is currently 108.3 days. Based on an average daily volume of 975 shares, the short-interest ratio is currently 108.3 days.

Avacta Group Stock Performance

AVCTF opened at $0.80 on Friday. Avacta Group has a 52 week low of $0.40 and a 52 week high of $1.11. The business has a fifty day simple moving average of $0.85 and a 200-day simple moving average of $0.87.

About Avacta Group

Avacta Group plc is a UK-based biotechnology company specializing in the discovery, development and commercialization of Affimer® biotherapeutics and diagnostic reagents. The company’s proprietary Affimer platform uses small, engineered protein scaffolds that can be tailored to bind specifically to target molecules, offering an alternative to traditional antibodies. Avacta operates two core divisions: Avacta Therapeutics, which focuses on novel treatments in oncology and immune-related diseases, and Avacta Analytical, which develops reagents and point-of-care diagnostic tests.

In its diagnostics business, Avacta has applied the Affimer technology to lateral flow assays, most notably for rapid detection of viral pathogens such as SARS-CoV-2.